Endocrine Abstracts

Teriparatide (TPTD – recombinant human parathyroid hormone 1–34) markedly increases bone mineral density (BMD) and reduces fracture risk. Sequential treatment with an antiresorptive agent is believed to preserve or further increase BMD. Strontium ranelate (SR) is thought to uncouple bone remodeling resulting in increased BMD and reduced fracture risk. In this prospective study, we aimed to evaluate the effect of SR on BMD in women with established osteoporosis previo...

Introduction: Bisphosponates have long been used with success in the treatment of Paget’s disease of bone (PDB). The aim of this study was to evaluate the early (up to three months) and late (at twelve months) scintigraphic, biochemical and clinical response to a single intravenous infusion of zoledronic acid (ZOL) in patients with PDB serially assessed for one year.Materials and methods: Nine patients with 30 bone lesions due to PDB were prospectiv...

Introduction: Adiponectin is secreted by adipocytes and has been linked to glucose and lipid regulation. Obesity, diabetes and atherosclerosis have been associated with reduced adiponectin levels. Orlistat lowers lipids and improves insulin sensitivity but its effect on other metabolic parameters is not known.The purpose of this study is to evaluate the influence of orlistat on metabolic and hormonal parameters of the adipose tissue.<p class="abstext...

Introduction: Resistin is a peptide hormone that is secreted from fat cells and its secretion is regulated from hormonal and dietary factors. In hypothyroid patients its levels are decreased.The purpose of this study is to evaluate the levels of circulating resistin in hypothyroid patients before and after thyroid function is normalized with thyroxin therapy.Materials and methods: Twenty (20) hypothyroid patients (2M, 18F) mean age...

Background: Fine-needle aspiration biopsy is the ‘gold standard’ in the preoperative management of thyroid nodules.Aim: The aim of this study was to investigate whether serum TSH is a predictor of thyroid malignancy in patients presenting with thyroid nodules.Subjects and methods: About 565 patients without overt thyroid dysfunction, who presented with palpable thyroid nodule(s) between 1988 and 2004 and underwent at leas...